Literature DB >> 22360401

Changes in natural killer cell subsets in pediatric liver transplant recipients.

Betty Pham1, Karine Piard-Ruster, Richard Silva, Amy Gallo, Carlos O Esquivel, Olivia M Martinez, Sheri M Krams.   

Abstract

NK cells are important in the immune response against tumors and virally infected cells. A balance between inhibitory and activating receptors controls the effector functions of NK cells. We examined the fate of circulating NK cells and the expression of the NK cell-activating receptors in pediatric liver transplant recipients. Blood specimens were collected from 38 pediatric liver transplant recipients before transplant, and at one wk, one, three, six, and nine months, and one yr post-transplant. PBMCs were isolated and analyzed for the levels of NK cell activation receptors NKp30, NKp46, and NKG2D in the CD56(dim) CD16(+) and CD56(bright) CD16(+/-) subsets of NK cells. We demonstrated that there is a significant decrease in the percentage of circulating NK cells post-transplant (pretransplant 7.69 ± 1.54 vs. one wk post-transplant 1.73 ± 0.44) in pediatric liver transplant recipients. Interestingly, NKp30 expression is significantly increased, while NKp46 and NKG2D levels remain stable on the NK cells that persist at one wk post-transplant. These data indicate that the numbers and subsets of circulating NK cells are altered in children after liver transplantation.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22360401      PMCID: PMC3306774          DOI: 10.1111/j.1399-3046.2012.01653.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  30 in total

1.  IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses.

Authors:  Hideaki Obara; Kazuhito Nagasaki; Christine L Hsieh; Yasuhiro Ogura; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Am J Transplant       Date:  2005-09       Impact factor: 8.086

2.  Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation.

Authors:  M Seiler; I Brabcova; O Viklicky; P Hribova; C Rosenberger; J Pratschke; A Lodererova; M Matz; C Schönemann; P Reinke; H-D Volk; K Kotsch
Journal:  Am J Transplant       Date:  2006-12-06       Impact factor: 8.086

3.  The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection.

Authors:  Jim Kim; Catherine K Chang; Tracy Hayden; Feng-Chun Liu; Jonathan Benjamin; Jessica A Hamerman; Lewis L Lanier; Sang-Mo Kang
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

4.  The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations.

Authors:  Hongbo Wang; Bartosz Grzywacz; David Sukovich; Valarie McCullar; Qing Cao; Alisa B Lee; Bruce R Blazar; David N Cornfield; Jeffrey S Miller; Michael R Verneris
Journal:  Blood       Date:  2007-05-10       Impact factor: 22.113

Review 5.  CD56bright natural killer (NK) cells: an important NK cell subset.

Authors:  Aurélie Poli; Tatiana Michel; Maud Thérésine; Emmanuel Andrès; François Hentges; Jacques Zimmer
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

6.  Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus.

Authors:  Tal I Arnon; Hagit Achdout; Ofer Levi; Gal Markel; Nivin Saleh; Gil Katz; Roi Gazit; Tsufit Gonen-Gross; Jacob Hanna; Efrat Nahari; Angel Porgador; Alik Honigman; Bodo Plachter; Dror Mevorach; Dana G Wolf; Ofer Mandelboim
Journal:  Nat Immunol       Date:  2005-04-10       Impact factor: 25.606

7.  NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

Authors:  Monia Draghi; Achal Pashine; Bharati Sanjanwala; Ketevan Gendzekhadze; Claudia Cantoni; David Cosman; Alessandro Moretta; Nicholas M Valiante; Peter Parham
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 8.  Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention.

Authors:  B Suárez-Alvarez; A López-Vázquez; J M Baltar; F Ortega; C López-Larrea
Journal:  Am J Transplant       Date:  2009-02       Impact factor: 8.086

9.  Phenotypically and functionally distinct subsets of natural killer cells in human PBMCs.

Authors:  Yan-ying Fan; Bin-yan Yang; Chang-you Wu
Journal:  Cell Biol Int       Date:  2007-09-07       Impact factor: 3.612

10.  Rapamycin, but not cyclosporine or FK506, alters natural killer cell function.

Authors:  Lu-En Wai; Masato Fujiki; Saori Takeda; Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2008-01-15       Impact factor: 4.939

View more
  7 in total

Review 1.  NK cells after transplantation: friend or foe.

Authors:  Uzi Hadad; Olivia Martinez; Sheri M Krams
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 2.  Immunological aspects of liver cell transplantation.

Authors:  Felix Oldhafer; Michael Bock; Christine S Falk; Florian W R Vondran
Journal:  World J Transplant       Date:  2016-03-24

3.  Differences in Peripheral Blood Lymphocytes between Brand-Name and Generic Tacrolimus Used in Stable Liver Transplant Recipients.

Authors:  Jong Man Kim; Choon Hyuck David Kwon; Jae-Won Joh; Dong Hyun Sinn; Gyu-Seong Choi; Jae Berm Park; Eun-Suk Kang; Suk-Koo Lee
Journal:  Med Princ Pract       Date:  2017-01-09       Impact factor: 1.927

4.  Mass cytometry reveals a distinct immunoprofile of operational tolerance in pediatric liver transplantation.

Authors:  Audrey H Lau; Matthew J Vitalone; Kelly Haas; Todd Shawler; Carlos O Esquivel; William E Berquist; Olivia M Martinez; Ricardo O Castillo; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2016-10-26

Review 5.  Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury.

Authors:  Miao Huang; Hao Cai; Bing Han; Yuhan Xia; Xiaoni Kong; Jinyang Gu
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

Review 6.  Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?

Authors:  Jennifer Halma; Stephen Pierce; Rebecca McLennan; Todd Bradley; Ryan Fischer
Journal:  Clin Transl Sci       Date:  2021-12-15       Impact factor: 4.438

7.  STAT4-associated natural killer cell tolerance following liver transplantation.

Authors:  K M Jamil; T J Hydes; K S Cheent; S A Cassidy; J A Traherne; J Jayaraman; J Trowsdale; G J Alexander; A-M Little; H McFarlane; M A Heneghan; M A Purbhoo; S I Khakoo
Journal:  Gut       Date:  2016-02-17       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.